386873009: Lisinopril (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\...

\Substance with renin-angiotensin system inhibitor mechanism of action (substance)\Angiotensin-converting enzyme inhibitor\Lisinopril (substance)

\Substance with hydrolase inhibitor mechanism of action (substance)\Peptide hydrolase inhibitor\Angiotensin-converting enzyme inhibitor\Lisinopril (substance)

\Drug or medicament (substance)\agent cardiovasculaire\Hypotensive agent (substance)\Substance with renin-angiotensin system inhibitor mechanism of action (substance)\Angiotensin-converting enzyme inhibitor\Lisinopril (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative\Substituted amide (substance)\Peptide\Dipeptide (substance)\Lisinopril (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative\Substituted amide (substance)\Peptide\Dipeptide (substance)\Lisinopril (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Lisinopril (substance)	Is a	Angiotensin-converting enzyme inhibitor	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Lisinopril (substance)	Has disposition	Angiotensin-converting enzyme inhibitor	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Lisinopril (substance)	Is a	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Lisinopril (substance)	Is a	Dipeptide (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing lisinopril (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lisinopril adverse reaction	Causative agent (attribute)	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lisinopril allergy	Causative agent (attribute)	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely lisinopril 2.5 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely lisinopril 5 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Lisinopril 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Lisinopril 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Lisinopril+diuretic (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Lisinopril 30 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Lisinopril 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydrochlorothiazide- and lisinopril-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lisinopril pseudoallergy	Causative agent (attribute)	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Lisinopril pseudoallergy	Causative agent (attribute)	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lisinopril pseudoallergy	Causative agent (attribute)	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely lisinopril 2.5 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely lisinopril 2.5 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely lisinopril 5 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely lisinopril 5 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lisinopril 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lisinopril 10 mg oral tablet	Has basis of strength substance (attribute)	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lisinopril 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lisinopril 20 mg oral tablet	Has basis of strength substance (attribute)	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lisinopril 30 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lisinopril 30 mg oral tablet	Has basis of strength substance (attribute)	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lisinopril 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lisinopril 40 mg oral tablet	Has basis of strength substance (attribute)	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet	Has basis of strength substance (attribute)	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet	Has precise active ingredient	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely lisinopril 2.5 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely lisinopril 5 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lisinopril 10 mg oral tablet	Has precise active ingredient	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lisinopril 20 mg oral tablet	Has precise active ingredient	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lisinopril 30 mg oral tablet	Has precise active ingredient	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lisinopril 40 mg oral tablet	Has precise active ingredient	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	False	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lisinopril-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydrochlorothiazide and lisinopril only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lisinopril only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only lisinopril in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lisinopril dihydrate	Is modification of (attribute)	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet	Has precise active ingredient	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet	Has basis of strength substance (attribute)	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Amlodipine and lisinopril only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Amlodipine- and lisinopril-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Amlodipine- and lisinopril-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Amlodipine and lisinopril only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and lisinopril 20 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and lisinopril 20 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Amlodipine (as amlodipine besilate) 5 mg and lisinopril 5 mg oral tablet	Has precise active ingredient	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Amlodipine (as amlodipine besilate) 5 mg and lisinopril 5 mg oral tablet	Has basis of strength substance (attribute)	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Lisinopril anhydrous	Is modification of (attribute)	True	Lisinopril (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461051018	Lisinopril (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1480987013	Lisinopril	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1461051018	Lisinopril (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1461051018	Lisinopril (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1480987013	Lisinopril	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1480987013	Lisinopril	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
49771000195112	lisinopril	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
63951000195110	Lisinopril	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
821001000172113	lisinopril	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
821001000172113	lisinopril	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
49771000195112	lisinopril	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
63951000195110	Lisinopril	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module